Do tamoxifen-resistant breast cancer cells possess cancer stem-like cell properties?
TAM-R MCF7 cells possess CSC characteristics and may be responsible for TAM resistance during breast cancer therapy.
These findings partially explain maraviroc-associated immunomodulatory effects and open new therapeutic expectations for the development of Treg-depleting immunotherapies.